SCHEMBL30356708

SCHEMBL30356708

O=Cc1c(Cl)ccnc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CCR1 P32246 1/20 0.33
CCR5 P51681 1/20 0.33
CCR8 P51685 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
DAO P14920 1/20 0.33
NFE2L2 Q16236 8/20 0.33
MAPT P10636 1/20 0.33
KMO O15229 1/20 0.32
KCNH2 Q12809 1/20 0.32
NAPRT Q6XQN6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25195292 1.00 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL304349 0.82 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL30255032 0.82 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL18297654 0.80 ERN1 (0.35) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL15240397 0.78 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL29956118 0.78 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATDP1SMN1; SMN2
SCHEMBL5212066 0.78 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL3649684 0.77 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL4322219 0.77 ERN1 (0.38) ALDH1A1MEN1KMT2ATDP1CCR1
SCHEMBL199582 0.77 CCR1 (0.32) ALDH1A1MEN1KMT2ATDP1CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185579-A1 INHIBITORS OF RHO-ASSOCIATED COILED-COIL KINASE Angion Biomedica Corp. (US) 2023-05-31 EP disclosed